US Stock Movement | Pneumococcal Vaccine Meets Late-Stage Clinical Trial Target, Vaxcyte (PCVX.US) Opens Over 50% Higher
智通财经2026/10/05 13:46According to reports from Zhihu Finance APP, on Monday, Vaxcyte (PCVX.US) opened over 50% higher, with gains of around 53% at the time of publication, and a market capitalization of 12.8 billions USD. The surge comes after the company's pneumococcal vaccine met its late-stage clinical trial goals. According to company assessments, VAX-31—a 31-valent pneumococcal conjugate vaccine under investigation—achieved positive topline results in its pivotal Phase III OPUS-1 trial. The trial evaluated the candidate vaccine’s safety, tolerability, and immunogenicity in adults to prevent invasive pneumococcal disease and pneumococcal pneumonia. In the OPUS-1 trial, VAX-31 achieved all pre-specified co-primary immunogenicity endpoints in subjects aged 50 years and older. These trial results will serve as the foundation for the upcoming Biologics License Application to be submitted to the U.S. Food and Drug Administration.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nasdaq rises 1.05%, Nvidia surges 2.12% leading active stocks
The Dow Jones closed up 0.18%, the Nasdaq rose 1.05%, and the S&P 500 gained 0.66%. Among the stocks with the highest trading volumes, Nvidia rose 2.12%, SpaceX surged 7.63%, Micron Technology fell 1.02%, and Tesla increased 2.2%.
Fitch says North American oil hedging currently faces book losses, natural gas traders lock in prices for 2028
Fitch Ratings has published a related assessment showing that oil hedging operations in North America have currently resulted in paper losses, while natural gas producers are moving to lock in favorable prices for 2028. It is understood that hedging activities by energy companies are primarily intended to counter commodity price fluctuations and stabilize operating cash flows. The recent paper losses in oil hedging are directly linked to the volatility in international oil prices. Meanwhile, natural gas producers' decisions to secure advantageous prices years in advance reflect the industry’s clear expectations regarding future supply and demand dynamics and price trends for natural gas. This early positioning aims to safeguard future profit margins and mitigate the operational uncertainties that potential market price fluctuations may bring.
Meta and Microsoft strive to reduce employees’ reliance on Claude: Meta’s internal usage has halved, and Microsoft has cut its budget by one-third.
Microsoft's internal Claude budget has been reduced by more than one-third from its peak, and the number of internal Claude Code users at Meta has dropped from around 60,000 to 30,000. Both companies emphasize that external customer demand is still growing, but the decline in internal usage puts pressure on Anthropic. According to Anthropic's IPO prospectus, two major clients together contributed about 25% of its revenue. Although the prospectus does not name specific clients, it is highly likely that Meta and Microsoft are these two clients or among them.
US Stock Market Movement: Charles River surged on October 5th, reaffirmed guidance, 2030 target, and CRO.
Crypto prices
More
